• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR Back to Search Results
Model Number G156
Device Problems Pacing Problem (1439); Inaccurate Synchronization (1609); Under-Sensing (1661)
Patient Problem Ventricular Fibrillation (2130)
Event Date 11/01/2023
Event Type  Injury  
Event Description
It was reported that there were concerns that this cardiac resynchronization therapy defibrillator (crt-d) delivered inappropriate therapy and triggered a ventricular arrhythmia.Technical services (ts) reviewed the event data and noted that this device appeared to deliver inappropriate anti-tachycardia pacing (atp) as a result of an atrial arrhythmia.There was evidence of functional undersensing of the atrial rhythm which contributed to the treatment decision.The atp appeared to trigger ventricular fibrillation (vf) which was then successfully terminated by an appropriate shock.Device reprogramming options were discussed with the health care professional (hcp).This device remains in service.No additional adverse patient effects were reported.
 
Event Description
It was reported that there were concerns that this cardiac resynchronization therapy defibrillator (crt-d) delivered inappropriate therapy and triggered a ventricular arrhythmia.Technical services (ts) reviewed the event data and noted that this device appeared to deliver inappropriate anti-tachycardia pacing (atp) as a result of an atrial arrhythmia.There was evidence of functional undersensing of the atrial rhythm which contributed to the treatment decision.The atp appeared to trigger ventricular fibrillation (vf) which was then successfully terminated by an appropriate shock.Device reprogramming options were discussed with the health care professional (hcp).This device remains in service.No additional adverse patient effects were reported.Further information was received indicating a concern of possible pacemaker mediated tachycardia (pmt).Ts reviewed the declared episode and noted that it appeared the event was more likely a result of sinus driven rhythm rather than true pmt.Possible device reprogramming options were provided.
 
Manufacturer Narrative
This report contains a correction to field h6: impact codes to include an additional code.
 
Event Description
It was reported that there were concerns that this cardiac resynchronization therapy defibrillator (crt-d) delivered inappropriate therapy and triggered a ventricular arrhythmia.Technical services (ts) reviewed the event data and noted that this device appeared to deliver inappropriate anti-tachycardia pacing (atp) as a result of an atrial arrhythmia.There was evidence of functional undersensing of the atrial rhythm which contributed to the treatment decision.The atp appeared to trigger ventricular fibrillation (vf) which was then successfully terminated by an appropriate shock.Device reprogramming options were discussed with the health care professional (hcp).This device remains in service.No additional adverse patient effects were reported.Further information was received indicating a concern of possible pacemaker mediated tachycardia (pmt).Ts reviewed the declared episode and noted that it appeared the event was more likely a result of sinus driven rhythm rather than true pmt.Possible device reprogramming options were provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18144445
MDR Text Key328224567
Report Number2124215-2023-64453
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534669
UDI-Public00802526534669
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/29/2016
Device Model NumberG156
Device Catalogue NumberG156
Device Lot Number103431
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/29/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
Patient Age78 YR
Patient SexMale
-
-